Barricade Therapeutics is Drug Discovery in United States that focus on molecular pharmacology business. Founded in 2017. They cover business area such as developer, oral and small molecule drug, cancer, complex molecule synthesis, chemistry, molecular pharmacology, healthcare provider.
2017
( 7 years old in 2024 )
Molecular Pharmacology
-
1120 South Freeway
Suite 103
Fort Worth, TX 76104
United States
Private
developeroral and small molecule drugcancercomplex molecule synthesischemistrymolecular pharmacologyhealthcare provider
* We use standard office opening hours in near Barricade Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Barricade Therapeutics is Drug Discovery business from United States that founded in 2017 (7 years old in 2024), Barricade Therapeutics business is focusing on Molecular Pharmacology.
Barricade Therapeutics headquarter office and corporate office address is located in 1120 South Freeway Suite 103 Fort Worth, TX 76104 United States.
Barricade Therapeutics was founded in United States.
In 2024, Barricade Therapeutics is currently focus on molecular pharmacology sector.
Above is snippet of Google Trends for "molecular pharmacology" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Barricade Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
